Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
José Casas-Martín
Observed names:
Jose Casas-Martin,
Jose Casas-Martín,
Jose Casas-martin,
Jose Casas‐Martin,
José Casas-Martin,
José G. Casas
show all 6
Institution:
European Organisation for Research and Treatment of Cancer
Observed institutions:
European Organisation for Research and Treatment of Cancer,
Hospital Universitario La Paz,
Hospital La Paz Institute for Health Research,
European Organisation for Research and Treatment of Cancer,
UCLouvain,
KU Leuven
show all 6
ORCID:
0000-0001-6962-8697
Observed ORCID:
0000-0001-6962-8697
OpenAlex ID:
A5005604318
Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea
2017
·
Carolina Cubillos-Zapata
, Jose Avendaño-Ortiz
, et al.
·
European Respiratory Journal
·
122
Monocytes inhibit NK activityviaTGF-β in patients with obstructive sleep apnoea
2017
·
Enrique Hernández-Jiménez
, Carolina Cubillos-Zapata
, et al.
·
European Respiratory Journal
·
62
PDF
Human inborn errors of the actin cytoskeleton affecting immunity: way beyond WAS and WIP
2019
·
Stuart G Tangye
, Giorgia Bucciol
, et al.
·
Immunology and Cell Biology
·
59
Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency
2021
·
Jin Yan Yap
, Leen Moens
, et al.
·
Journal of Clinical Immunology
·
54
PDF
PD-L1 Overexpression During Endotoxin Tolerance Impairs the Adaptive Immune Response in Septic Patients via HIF1α
2017
·
José Avendaño-Ortiz
, Charbel Maroun-Eid
, et al.
·
The Journal of Infectious Diseases
·
53
PDF
Systemic Inflammation and Myelofibrosis in a Patient with Takenouchi-Kosaki Syndrome due to CDC42 Tyr64Cys Mutation
2020
·
Giorgia Bucciol
, Bethany Pillay
, et al.
·
Journal of Clinical Immunology
·
50
PDF
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042
2023
·
Sybren L. N. Maas
, Philipp Sievers
, et al.
·
Acta Neuropathologica
·
33
PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
2018
·
Ramón Cantero-Cid
, José Casas-Martin
, et al.
·
BMC Cancer
·
31
PDF
A System Dynamics Model to Predict the Human Monocyte Response to Endotoxins
2017
·
Enrique Álvarez
, Víctor Toledano
, et al.
·
Frontiers in Immunology
·
13
PDF
Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG “PARCT”
2025
·
Rudolf Stadler
, Gabriele Roccuzzo
, et al.
·
European Journal of Cancer
·
12
PDF
Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6).
2022
·
Thomas Meyskens
, Otto Metzger
, et al.
·
Journal of Clinical Oncology
·
9
Histone Acetyl Transferase 1 Is Overexpressed in Poor Prognosis, High-grade Meningeal and Glial Brain Cancers: Immunohistochemical and Aptahistochemical Study
2024
·
Sandra Bargiela-Cuevas
, María Marin
, et al.
·
Journal of Histochemistry & Cytochemistry
·
5
Abstract OT1-04-01: AMEERA-6: Phase 3 Study of Adjuvant Amcenestrant Versus Tamoxifen for Patients With Hormone Receptor-Positive Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity
2023
·
Otto Metzger
, Christina Herold
, et al.
·
Cancer Research
·
5
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial
2022
·
Solange Peters
, Igor Letovanec
, et al.
·
Lung Cancer
·
2
PDF
Abstract PO2-19-11: NOBLE – Neoadjuvant Olaparib and Durvalumab for patients with BRCA-associated TripLE Negative Breast Cancer
2024
·
Emanuel Buhrer
, Eleni Xenophontos
, et al.
·
Cancer Research
·
1
Abstract 6770: Spatial characterization of immune microenvironment from early onset metastatic colorectal cancer (EOmCRC) showed a dual prognostic role for IDO1 expression
2023
·
Raghavendar Thyagaraja Nagaraju
, Jakub Franczak
, et al.
·
Cancer Research
·
1
Observing the cancer microenvironment in mycosis fungoides following immune checkpoint blockade
2025
·
Duncan Murray
, Samantha Drennan
, et al.
·
European Journal of Cancer
Faculty Opinions recommendation of Biallelic mutations in DNA ligase 1 underlie a spectrum of immune deficiencies.
2019
·
Isabelle Meyts
, José Casas-Martín
·
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Show more works
View as search
Works count:
18
Citation count:
512
H-index:
10
I10-index:
10
Year
Topic
Type